-
101
-
102
Neurotrophin-3 as a mediator in the link between PM2.5 exposure and psychiatric disorders: A Mendelian randomization study
Published 2025-01-01Subjects: Get full text
Article -
103
Association between major depressive disorder or depressive symptoms and the risk of vascular complications among patients with type 2 diabetes, and the mediating role of metabolic biomarkers: an analysis of the UK Biobank cohortResearch in context
Published 2025-01-01Subjects: “…Major depressive disorder…”
Get full text
Article -
104
High-Frequency and Low-Intensity Patterned Transcranial Magnetic Stimulation over Left Dorsolateral Prefrontal Cortex as Treatment for Major Depressive Disorder: A Report of 3 Cases
Published 2021-01-01“….), produce therapeutic effects in major depressive disorder. We report the application of high-frequency and low-intensity patterned magnetic pulses over the left prefrontal dorsolateral cortex in three subjects diagnosed with clinical major depressive disorder. …”
Get full text
Article -
105
Therapeutic effect of proprioceptive dolphin assisted activities on health-related quality of life and muscle tension, biomechanical and viscoelastic properties in major depressive disorder adults: case analysis
Published 2025-01-01“…Despite other present diagnostic features adults with major depressive disorder experience psychomotor changes, dysphoria, anhedonia, impaired concentration, and suicidal thoughts. …”
Get full text
Article -
106
Dynamic Impact of the Sleep Disorder, Depression and Anxiety on the Cognitive Function in the First-Episode Depressive Patients
Published 2025-02-01Subjects: “…major depressive disorder…”
Get full text
Article -
107
Comparative antidepressant effects and safety of intravenous racemic ketamine, psilocybin and theta burst stimulation for major depressive disorder: A systematic review and network meta‐analyses of randomized controlled trials
Published 2024-12-01“…Abstract The individual efficacy and safety of intravenous racemic (IV) ketamine, psilocybin, and theta burst stimulation (TBS) for major depressive disorder have been demonstrated through meta‐analyses of randomized controlled trials (RCTs), but the comparative usefulness of these novel treatments has not yet been fully examined. …”
Get full text
Article -
108
Beneficial and harmful effects of duloxetine versus placebo, ‘active placebo’ or no intervention for adults with major depressive disorder: a systematic review with meta-analysis and trial sequential analysis of randomised clinical trials
Published 2025-02-01“…Objectives To assess the beneficial and harmful effects of duloxetine versus ‘active placebo’, placebo or no intervention for adults with major depressive disorder.Design Systematic review with meta-analysis and trial sequential analysis of randomised trials.Data sources Cochrane Central Register of Controlled Trials, MEDLINE, Embase, PsycINFO and other relevant databases up until January 2023. …”
Get full text
Article -
109
-
110
-
111
-
112
Integrated treatment of depression and moderate to severe alcohol use disorder in women shows promise in routine alcohol use disorder care – a pilot study
Published 2025-02-01Subjects: “…major depressive disorder…”
Get full text
Article -
113
Oleanolic Acid Cubic Liquid Crystal Nanoparticle-Based Thermosensitive Gel Attenuates Depression Symptoms in Chronic Unpredictable Mild Stress Rats
Published 2025-02-01Subjects: Get full text
Article -
114
Developing a translational research framework for MDD: combining biomolecular mechanisms with a spiraling risk factor model
Published 2025-01-01Subjects: “…MDD (major depressive disorder)…”
Get full text
Article -
115
PUPIL DIAMETER AND MACHINE LEARNING FOR DEPRESSION DETECTION: A COMPARATIVE STUDY WITH DEEP LEARNING MODELS
Published 2024-12-01Subjects: Get full text
Article -
116
-
117
-
118
Systematic review of bidirectional interaction between gut microbiome, miRNAs, and human pathologies
Published 2025-02-01Subjects: Get full text
Article -
119
Coupling Bio-Resonance Neurotechnology (BRNT) and Dual Hemispheric Repetitive Transcranial Magnetic Stimulation (rTMS) Reduces Comorbid Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD) as Demonstrated by PHQ-9 and GAD-7: Pilot Case Series
Published 2025-02-01“…., Colombia*These authors contributed equally to this workCorrespondence: Kenneth Blum, Email drd2gene@gmail.comAbstract: Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD) are prevalent comorbidities related to a greater likelihood of poor treatment outcomes and prolonged treatment for Reward Deficiency Syndrome (RDS) behaviors. …”
Get full text
Article -
120
Causal relationship between affect disorders and endometrial cancer: a Mendelian randomisation study
Published 2024-12-01“…Only the effect of major depressive disorder under the inverse variance weighting method increasing the risk of endometrial endometrial cancer (effect 0.004 p = 0.047) and the effect of major depressive disorder under the MR-Egger method decreasing endometrial cancer of all pathology types (effect −0.691 p = 0.015) were statistically significant. …”
Get full text
Article